ChemRoutes Corporation is a private drug discovery technology provider operating at the interface of organic chemistry, chemical biology, drug discovery and nanotechnology. We focus on early stage drug discovery to pre-clinical research. Our proprietary and novel small molecule based scaffolds, building blocks, templates, chemical arrays and new chemical target research spans infectious, neurodegenerative and metabolic diseases, pain , inflammation and oncology. (Bio AB)